Phototoxicity: Its Mechanism and Animal Alternative Test Methods
Tóm tắt
The skin exposure to solar irradiation and photoreactive xenobiotics may produce abnormal skin reaction, phototoxicity. Phototoxicity is an acute light-induced response, which occurs when photoreacive chemicals are activated by solar lights and transformed into products cytotoxic against the skin cells. Multifarious symptoms of phototoxicity are identified, skin irritation, erythema, pruritis, and edema that are similar to those of the exaggerated sunburn. Diverse organic chemicals, especially drugs, are known to induce phototoxicity, which is probably from the common possession of UV-absorbing benzene or heterocyclic rings in their molecular structures. Both UVB (290~320 nm) and UVA (320~400 nm) are responsible for the manifestation of phototoxicity. Absorption of photons and absorbed energy (hv) by photoactive chemicals results in molecular changes or generates reactive oxygen species and depending on the way how endogenous molecules are affected by phototoxicants, mechanisms of phototoxcity is categorized into two modes of action: Direct when unstable species from excited state directly react with the endogenous molecules, and indirect when endogeneous molecules react with secondary photoproducts. In order to identify phototoxic potential of a chemical, various test methods have been introduced. Focus is given to animal alternative test methods, i.e., in vitro, and in chemico assays as well as in vivo. 3T3 neutral red uptake assay, erythrocyte photohemolysis test, and phototoxicity test using human 3-dimensional (3D) epidermis model are examples of in vitro assays. In chemico methods evaluate the generation of reactive oxygen species or DNA strand break activity employing plasmid for chemicals, or drugs with phototoxic potential.
Tài liệu tham khảo
Freeman, A.K. and Gordon, M. (2006) Dermatologic diseases and problems. Geriatric Medicine (4th edition), Springer, New York, pp. 869–881.
Boudon, S.M., Morandi, G., Prideaux, B., Staab, D., Junker, U., Odermatt, A., Stoeckli, M. and Bauer, D. (2014) Evaluation of Sparfloxacin Distribution by Mass Spectrometry Imaging in a Phototoxicity Model. J. Am. Soc. Mass Spectrom., 25, 1803–1809.
OECD. (2004) Test No. 432: In vitro 3T3 NRU Phototoxicity Test. OECD, Paris: OECD Publishing. No. 432.
Lugovic, L., Situm, M., Ozanic-Bulic, S. and Sjerobabski-Masnec, I. (2007) Phototoxic and photoallergic skin reactions. Coll. Antropol., 31 Suppl 1, 63–67.
FDA U. (2003) Guidance for industry - Photosafety Testing. FDA, US: FDA Publishing, pp. 1–22.
Tønnesen, H.H. (2001) Formulation and stability testing of photolabile drugs. Int. J. Pharm., 225, 1–14.
Gonçalo, M. (2011) Phototoxic and photoallergic reactions. Contact Dermatitis, Springer, pp. 361–376.
Ferguson, J. (2002) Photosensitivity due to drugs. Photoder-matol. Photoimmunol. photomed., 18, 262–269.
Adachi, T., Satou, Y., Satou, H., Shibata, H., Miwa, S., Iwase, Y., Yamamoto, T., Nishida, A. and Masutomi, N. (2015) Assessment of 8-methosypsoralen, lomefloxacin, sparfloxacin, and Pirfenidone phototoxicity in Long-Evans rats. Int. J. Toxicol., 34, 16–23.
Boudon, S.M., Plappert-Helbig, U., Odermatt, A. and Bauer, D. (2014) Characterization of vemurafenib phototoxicity in a mouse model. Toxicol. Sci., 137, 259–267.
Yazici, A.C., Baz, K., Ikizoglu, G., Kokturk, A., Uzumlu, H. and Tataroglu, C. (2004) Celecoxib?induced photoallergic drug eruption. Int. J. Dermatol., 43, 459–461.
Onoue, S., Seto, Y., Kato, M., Aoki, Y., Kojo, Y. and Yamada, S. (2013) Inhalable powder formulation of pirfenidone with reduced phototoxic risk for treatment of pulmonary fibrosis. Pharm. Res., 30, 1586–1596.
Seto, Y., Inoue, R., Kato, M., Yamada, S. and Onoue, S. (2013) Photosafety assessments on pirfenidone: photochemical, photobiological, and pharmacokinetic characterization. J. Photochem. Photobiol. B, 120, 44–51.
Chignell, C.F., Motten, A.G. and Buettner, G.R. (1985) Photoinduced free radicals from chiorpromazine and related phenothiazines: relationship to phenothiazine-induced photosensitization. Environ. Health Perspect., 64, 103–110.
Kochevar, K.E. (1981) Phototoxicity mechanisms: chlorpromazine photosensitized damage to DNA and cell membranes. J. Invest. Dermatol., 77, 59–64.
ICH. (2014) ICH guideline S10 on photosafety evaluation of pharmaceuticals. ICH, US: FDA.
OECD. (1981) TG101: UV-VIS Absorption Spectra. OECD, Paris: OECD, pp. 1–6.
Garg, S., Rose, A.L. and Waite, T.D. (2011) Photochemical production of superoxide and hydrogen peroxide from natural organic matter. Geochim. Cosmochim. Acta, 75, 4310–4320.
Sayre, R.M., Dowdy, J.C., Gerwig, A.J., Shlelds, W.J. and Lioyd, R.V. (2005) Unexpected photolysis of the sunscreen octinoxate in the presence of the sunscreen avobenzone. Photochem. Photobiol., 81, 452–456.
ICH. (2013) Photosafety Evaluation of Pharmaceuticals S10. ICH, US: FDA, pp. 1–15.
Vinardell, M.P. (2015) The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS). Regul. Toxicol. Pharmacol., 71, 198–204.
Haranosono, Y., Kurata, M. and Sakaki, H. (2014) Establishment of an in silico phototoxicity prediction method by combining descriptors related to photo-absorption and photoreaction. J. Toxicol. Sci., 39, 655–664.
Onoue, S. and Tsuda, Y. (2006) Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm. Res., 23, 156–164.
Onoue, S., Kawamura, K., Igarashi, N., Zhou, Y., Fujikawa, M., Yamada, H., Tsuda, Y., Seto, Y. and Yamada, S. (2008) Reactive oxygen species assay-based risk assessment of druginduced phototoxicity: classification criteria and application to drug candidates. J. Pharm. Biomed. Anal., 47, 967–972.
Guideline IHT. (2009) ICH guideline M3 (R2) on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. ICH, European Medicines Agency, pp. 1–26.
Bauer, D., Averett, L.A., De Smedt, A., Kleinman, M.H., Muster, W., Pettersen, B.A. and Robles, C. (2014) Standardized UV-vis spectra as the foundation for a threshold-based, integrated photosafety evaluation. Regul. Toxicol. Pharmacol., 68, 70–75.
Diffey, B.L. (2002) Sources and measurement of ultraviolet radiation. Methods, 28, 4–13.
Wang, C.C., Xia, Q., Li, M., Wang, S., Zhao, Y., Tolleson, W.H., Yin, J.J. and Fu, P.P. (2014) Metabolic activation of pyr-rolizidine alkaloids leading to phototoxicity and photogenotoxicity in human HaCaT keratinocytes. J. Environ. Sci. Health Part C Environ. Carcinog. Ecotoxicol. Rev., 32, 362–384.
Schümann, J., Boudon, S., Ulrich, P., Loll, N., Garcia, D., Schaffner, R., Streich, J., Kittel, B. and Bauer, D. (2014) Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals. Toxicol. Sci., 139, 245–256.
Spielmann, H., Balls, M., Brand, M., Döring, B., Holzhütter, H.G., Kalweit, S., Klecak, G., Eplattenier, H.L., Liebsch, M., Lovell, W.W., Maurer, T., Moldenhauer, F., Moore, L., Pape, W.J., Pfanenbecker, U., Potthast, J., De Silva, O., Steiling, W. and Willshaw, A. (1994) EEC/COLIPA project on in vitro phototoxicity testing: First results obtained with a Balb/c 3T3 cell phototoxicity assay. Toxicol. In Vitro, 8, 793–796.
Peters, B. and Holzhütter, H.G. (2002) In vitro phototoxicity testing: development and validation of a new concentration response analysis software and biostatistical analyses related to the use of various prediction models. Altern. Lab. Anim., 30, 415–432.
Pape, W.J., Maurer, T., Pfannenbecker, U. and Steiling, W. (2001) The red blood cell phototoxicity test (photohaemolysis and haemoglobin oxidation): EU/COLIPA validation programme on phototoxicity (phase II). Altern. Lab. Anim., 29, 145–162.
Yamamoto, T., Tsurumaki, Y., Takei, M., Hosaka, M. and Oomori, Y. (2001) In vitro method for prediction of the photo-toxic potentials of fluoroquinolones. Toxicol. In Vitro, 15, 721–727.
Sugiyama, M., Itagaki, H., Hariya, T., Murakami, N. and Kato, S. (1994) In vitro assays to predict phototoxicity of chemicals:(I) Red blood cell hemolysis assay. AATEX, 2, 183–191.
Netzaff, F., Lehr, C.M., Wertz, P.W. and Schaefer, U.F. (2005) The human epidermis models EpiSkin (R), SkinEthic (R) and EpiDerm (R): An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur. J. Pharm. Biopharm., 60, 167–178.
Portes, P., Pygmalion, M.J., Popovic, E., Cottin, M. and Mariani, M. (2002) Use of human reconstituted epidermis Episkin® for assessment of weak phototoxic potential of chemical compounds. Photodermatol. Photoimmunol. Photomed., 18, 96–102.
Bernard, F.X., Barrault, C., Deguercy, A., De Wever, B. and Rosdy, M. (2000) Development of a highly sensitive in vitro phototoxicity assay using the SkinEthicTM reconstructed human epidermis. Cell Biol. Toxicol., 16, 391–400.
Aardema, M.J., Barnett, B.B., Mun, G.C., Dahl, E.L., Curren, R.D., Hewitt, N.J. and Pfuhler, S. (2013) Evaluation of chemicals requiring metabolic activation in the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res., 750, 40–49.
Lelièvre, D., Justine, P., Christiaens, F., Bonaventure, N., Coutet, J., Marrot, L. and Cotovio, J. (2007) The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol. In Vitro, 21, 977–995.
Reus, A.A., Reisinger, K., Downs, T.R., Carr, G.J., Zeller, A., Corvi, R., Krul, C.A. and Pfuhler, S. (2013) Comet assay in reconstructed 3D human epidermal skin models--investigation of intra- and inter-laboratory reproducibility with coded chemicals. Mutagenesis, 28, 709–720.
Matsumoto, N., Akimoto, A., Kawashima, H. and Kim, S. (2010) Comparative study of skin phototoxicity with three drugs by an in vivo mouse model. J. Toxicol. Sci., 35, 97–100.
Wagai, N. and Tawara, K. (1992) Possible reasons for differences in phototoxic potential of a 5 quinolone antibacterial agents: generation of toxic oxygen. Free Radical Res. Commun., 17, 387–398.
Clewell, H.J. 3rd. (1993) Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing. Toxicol. Lett., 68, 101–117.
Henry, B., Foti, C. and Alsante, K. (2009) Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule? J. Photochem. Photobiol. B, 96, 57#x2013;62.